CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Scientific Officer bought 27,273 shares at $1.10 ($30,000)
- 4 Open-market buy Director bought 181,818 shares at $1.10 ($200,000)
- 4 Other acquisition Director acquired 34,958 shares (other)
- 4/A Grant or award Director acquired 1,818 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Chief Financial Officer acquired 761 shares (other)
- 4 Open-market buy Director bought 5,000 shares at an average $3.40 ($17,021)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Scientific Officer acquired 2,013 shares (option exercise)
- 4 Grant or award Chief Scientific Officer acquired 80,088 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 228,978 shares (grant or award)
- 4 Grant or award 10% owner acquired 30,793,670 shares (grant or award)
Page 10 of 28 · 550 filings